Justin Brogan is an associate in the firm’s Business Law department and a member of its Technology and Life Sciences group. Justin works with clients on a wide array of corporate matters, including venture capital and growth equity financings, mergers and acquisitions, capital markets transactions and SEC compliance. He joined Goodwin in 2022.
Experience
Justin’s recent representations, among others, include:
Capital Markets and Mergers & Acquisitions:
- Klaviyo in its $659 million initial public offering and secondary common stock offerings
- Klaviyo in its acquisition of Gatsby Tech
- HI-Bio in its up to sale to Biogen
- HubSpot in its acquisition of Dashworks Technologies
- Markforged Holding Corporation (NYSE: MKFG) in its sale to Nano Dimension (Nasdaq: NNDM)
- DataRobot in its acquisition of Agnostiq
- Ultimate.ai in its sale to Zendesk
- Vatn Systems in its acquisition of Crewless Marine Acoustics
- Veracode in its acquisition of Longbow Security
- Xcoding Labs in its sale to Datadog
- Verisma Systems in its acquisition of ScanSTAT Technologies
- Verisma Systems in its acquisition of Olah Healthcare Technology
Private Financings:
- General Catalyst in various investments
- Spark Capital in various investments
- webAI in its preferred stock financing
- FamilyWell in its Series Seed and Series A financings
- Novo Holdings in its Series E investment in Cleveland Diagnostics
- Mantra Health in its Series A-1 financing
Areas of Practice
Professional Activities
Justin is a member of the Boston Bar Association and Massachusetts LGBTQ Bar Association.
Credentials
Education
JD2022
Boston University School of Law
BA2018
Tufts University
(summa cum laude)
Admissions
Bars
- Massachusetts